The formation of ex20ins leads to changes in the C-helix conformation, forming a narrow drug-binding pocket in the ATP-binding region, which makes it difficult to interact with regular EGFR, conventional EGFR-TKIs, and NSCLC cell lines (22). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.